|
1
|
Nelson LM: Clinical practice. Primary
ovarian insufficiency. N Engl J Med. 360:606–614. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Tucker EJ, Grover SR, Bachelot A, Touraine
P and Sinclair AH: Premature ovarian insufficiency: New
perspectives on genetic cause and phenotypic spectrum. Endocr Rev.
37:609–635. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gowri V, Al Shukri M, Al-Farsi FA,
Al-Busaidi NA, Dennison D, Al Kindi S, Daar S, Al Farsi K and
Pathare AV: Aetiological profile of women presenting with premature
ovarian failure to a single tertiary care center in Oman. Post
Reprod Health. 21:63–68. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
European Society for Human Reproduction
and Embryology (ESHRE) Guideline Group on POI, ; Webber L, Davies
M, Anderson R, Bartlett J, Braat D, Cartwright B, Cifkova R, de
Muinck Keizer-Schrama S, Hogervorst E, et al: ESHRE guideline:
management of women with premature ovarian insufficiency. Hum
Reprod. 31:926–937. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jiao X, Ke H, Qin Y and Chen ZJ: Molecular
genetics of premature ovarian insufficiency. Trends Endocrinol
Metab. 29:795–807. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Rossetti R, Ferrari I, Bonomi M and
Persani L: Genetics of primary ovarian insufficiency. Clin Genet.
91:183–198. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Huhtaniemi I, Hovatta O, La Marca A,
Livera G, Monniaux D, Persani L, Heddar A, Jarzabek K, Laisk-Podar
T, Salumets A, et al: Advances in the molecular pathophysiology,
genetics, and treatment of primary ovarian insufficiency. Trends
Endocrinol Metab. 29:400–419. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zangen D, Kaufman Y, Zeligson S, Perlberg
S, Fridman H, Kanaan M, Abdulhadi-Atwan M, Abu Libdeh A, Gussow A,
Kisslov I, et al: XX ovarian dysgenesis is caused by a PSMC3IP/HOP2
mutation that abolishes coactivation of estrogen-driven
transcriptio. Am J Hum Genet. 89:572–579. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sansam CL and Pezza RJ: Connecting by
breaking and repairing: Mechanisms of DNA strand exchange in
meiotic recombination. FEBS J. 282:2444–2457. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhao W and Sung P: Significance of ligand
interactions involving Hop2-Mnd1 and the RAD51 and DMC1
recombinases in homologous DNA repair and XX ovarian dysgenesis.
Nucleic Acids Res. 43:4055–4066. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Petukhova GV, Romanienko PJ and
Camerini-Otero RD: The Hop2 protein has a direct role in promoting
interhomolog interactions during mouse meiosis. Dev Cell.
5:927–936. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Biswas L, Tyc K, El Yakoubi W, Morgan K,
Xing J and Schindler K: Meiosis interrupted: The genetics of female
infertility via meiotic failure. Reproduction. 161:R13–R35. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Al-Agha AE, Ahmed IA, Nuebel E, Moriwaki
M, Moore B, Peacock KA, Mosbruger T, Neklason DW, Jorde LB, Yandell
M and Welt CK: Primary ovarian insufficiency and azoospermia in
carriers of a homozygous PSMC3IP stop gain mutation. J Clin
Endocrinol Metab. 103:555–563. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yang X, Touraine P, Desai S, Humphreys G,
Jiang H, Yatsenko A and Rajkovic A: Gene variants identified by
whole-exome sequencing in 33 French women with premature ovarian
insufficiency. J Assist Reprod Genet. 36:39–45. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Richards S, Aziz N, Bale S, Bick D, Das S,
Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, et al:
Standards and guidelines for the interpretation of sequence
variants: A joint consensus recommendation of the American college
of medical genetics and genomics and the association for molecular
pathology. Genet Med. 17:405–424. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Schubert S, Ripperger T, Rood M, Petkidis
A, Hofmann W, Frye-Boukhriss H, Tauscher M, Auber B, Hille-Betz U,
Illig T, et al: GT198 (PSMC3IP) germline variants in early-onset
breast cancer patients from hereditary breast and ovarian cancer
families. Genes Cancer. 8:472–483. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Achyut BR, Zhang H, Angara K, Mivechi NF,
Arbab AS and Ko L: Oncoprotein GT198 vaccination delays tumor
growth in MMTV-PyMT mice. Cancer Lett. 476:57–66. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Capdevila-Busquets E, Badiola N, Arroyo R,
Alcalde V, Soler-López M and Aloy P: Breast cancer genes PSMC3IP
and EPSTI1 play a role in apoptosis regulation. PLoS One.
10:e01153522015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Nathansen J, Lukiyanchuk V, Hein L, Stolte
MI, Borgmann K, Löck S, Kurth I, Baumann M, Krause M, Linge A, et
al: Oct4 confers stemness and radioresistance to head and neck
squamous cell carcinoma by regulating the homologous recombination
factors PSMC3IP and RAD54L. Oncogene. 40:4214–4228. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Pang J, Gao J, Zhang L, Mivechi NF and Ko
L: GT198 is a target of oncology drugs and anticancer herbs. Front
Oral Health. 2:6794602020. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lin T, Zhang Y, Zhang T, Steckler RA and
Yang X: Hop2 interacts with the transcription factor CEBPα and
suppresses adipocyte differentiation. J Biol Chem. 297:1012642021.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhao W, Saro D, Hammel M, Kwon Y, Xu Y,
Rambo RP, Williams GJ, Chi P, Lu L, Pezza RJ, et al: Mechanistic
insights into the role of Hop2-Mnd1 in meiotic homologous DNA
pairing. Nucleic Acids Res. 42:906–917. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Norling A, Hirschberg AL, Karlsson L,
Rodriguez-Wallberg KA, Iwarsson E, Wedell A and Barbaro M: No
mutations in the PSMC3IP gene identified in a Swedish cohort of
women with primary ovarian insufficiency. Sex Dev. 8:146–150. 2014.
View Article : Google Scholar : PubMed/NCBI
|
